Abstract：Objective To review the research progress of hepatectomy for liver cancer. Methods To retrieve the related literatures about the progress on reasonable choice of hepatectomy for liver cancer in PubMed and Wanfang databases by the key words of "liver cancer" and "hepatectomy" from Jan. 2009 to Jan. 2015, and then analyze and summarize the recent research progress at home and abroad. Results Hepatectomy is one of the most effective therapies for live cancer. Preoperative detailed assessment should be carried out on the liver function of the residual. But the clinical selection of proper liver resection remains controversial. The disputes of liver resection are mainly concentrated on the patients with solitary large tumors, multiple tumors and liver cancer with portal vein tumor thrombus as well as cirrhosis. These controversies on the choice of surgical procedure for liver cancer may have significant impact on the efficacy of patients. Conclusions Comprehensive preoperative evaluation, individualized treatment selection of rational operation and liver resection based on liver segment are essential for improving patients' survival rate.
徐伟,李高峰,吴越,屈淑平,吴东. 肝癌肝切除术的合理选择[J]. 中华解剖与临床杂志, 2016, 21(3): 269-272.
Xu Wei, Li Gaofeng, Wu Yue, Qu Shuping, Wu Dong. The reasonable choice of hepatectomy for liver cancer. Chinese Journal of Anatomy and Clinics, 2016, 21(3): 269-272.
Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma[J]. Hepatology, 2002, 35(3): 519-524. DOI:10.1053/jhep.2002.32089
[2]
Kobayashi T, Itamoto T, Tashiro H, et al. Tumor-related factors do not influence the prognosis of solitary hepatocellular carcinoma after partial hepatectomy[J]. J Hepatobiliary Pancreat Sci, 2011, 18(5): 689-699. DOI: 10.1007/s00534-011-0379-4
[3]
Du ZG, Wei YG, Chen KF, et al. An accurate predictor of liver failure and death after hepatectomy: a single institution′s experience with 478 consecutive cases[J]. World Gastroenterol, 2014, 20(1): 274-281. DOI:10.3748/wjg.v20.i1.274
[4]
Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure[J]. Gastroenterology, 1996, 111(4): 1018-1022
[5]
Pulitano C, Crawford M, Joseph D, et al. Preoperative assessment of postoperative liver function: the importance of residual liver volume[J]. J Surg Oncol, 2014, 110(4): 445-450. DOI:10.1002/jso.23671
[6]
Cescon M, Colecchia A, Cucchetti A, et al. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma[J]. Ann Surg, 2012, 256(5): 706-713. DOI:10.1097/SLA.0b013e3182724ce8
[7]
Kim MY, Cho MY, Baik SK, et al. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension[J]. J Hepatol, 2011, 55(5): 1004-1009. DOI:10.1016/j.jhep.2011.02.012
[8]
Santambrogio R, Kluger MD, Costa M, et al. Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh′s A cirrhosis: is clinical evidence of portal hypertension a contraindication?[J]. HPB (Oxford), 2013, 15(1): 78-84. DOI:10.1111/j.1477-2574.2012.00594.x
[9]
Chen X, Zhai J, Cai X, et al. Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis[J]. Br J Surg, 2012, 99(12): 1701-1710. DOI:10.1002/bjs.8951
Hasegawa K, Kokudo N, Imamura H, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma[J]. Ann Surg, 2005, 242(2): 252-259
[12]
Zhou Y, Xu D, Wu L, et al. Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma[J]. Langenbecks Arch Surg, 2011, 396(7): 1109-1117. DOI:10.1007/s00423-011-0784-9
[13]
Strasberg SM, Phillips C. Use and dissemination of the Brisbane 2000 nomenclature of liver anatomy and resections[J]. Ann Surg, 2013, 257(3): 377-382. DOI:10.1097/SLA.0b013e31825a01f6
[14]
Cucchetti A, Qiao GL, Cescon M, et al. Anatomic versus nonanatomic resection in cirrhotic patients with early hepatocellular carcinoma[J]. Surgery, 2014, 155(3): 512-521. DOI:10.1016/j.surg.2013.10.009
[15]
Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases.Management of hepatocellular carcinoma[J]. Hepatology, 2005, 42(5): 1208-1236
[16]
Berzigotti A, Reig M, Abraldes JG, et al. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis[J]. Hepatology, 2015, 61(2): 526-536. DOI:10.1002/hep.27431
[17]
Cucchetti A, Ercolani G, Vivarelli M, et al. Is portal hypertension a contraindication to hepatic resection?[J]. Ann Surg, 2009, 250(6): 922-928. DOI:10.1097/SLA.0b013e3181b977a5
[18]
Ruzzenente A, Valdegamberi A, Campagnaro T, et al. Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated?[J]. World J of Gastroenterol, 2011, 17(46): 5083-5088. DOI:10.3748/wjg.v17.i46.5083
[19]
Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma[J]. Gastroenterology, 2008, 134(7): 1908-1916. DOI:10.1053/j.gastro.2008.02.091
[20]
Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and Advanced-Stage hepatocellular carcinoma[J]. Ann Surg, 2013, 260(2): 329-340. DOI:10.1097/SLA.0000000000000236
[21]
Yang T, Lau WY, Zhang H, et al. Should surgery be carried out in patients with hepatocellular carcinoma with portal hypertension?[J]. Hepatology, 2015, 62(3): 976. DOI:10.1002/hep.27703
[22]
Kim SU, Oh HJ, Wanless IR, et al. The laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis[J]. J Hepatol, 2012, 57(3): 556-563. DOI:10.1016/j.jhep.2012.04.029
[23]
Yamashita Y, Taketomi A, Itoh S, et al. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience[J]. J Am Coll Surg, 2007, 205(1): 19-26. DOI:10.1016/j.jamcollsurg.2007.01.069
[24]
Liau KH, Ruo L, Shia J, et al. Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma[J]. Cancer, 2005, 104(9): 1948-1955. DOI:10.1002/cncr.21415
[25]
Cho YB, Lee KU, Lee HW, et al. Outcomes of hepatic resection for a single large hepatocellular carcinoma[J]. World J Surg, 2007, 31(4): 795-801. DOI:10.1007/s00268-006-0359-z
[26]
Pandey D, Lee KH, Wai CT, et al. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection[J]. Ann Surg Oncol, 2007, 14(10): 2817-2823. DOI:10.1245/s10434-007-9518-1
[27]
Tsoulfas G, Mekras A, Agorastou P, et al. Surgical treatment for large hepatocellular carcinoma: does size matter?[J]. ANZ J Surg, 2012, 82(7/8): 510-517. DOI:10.1111/j.1445-2197.2012.06079.x
[28]
Zhang H, Yuan SX, Dai SY, et al. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion[J]. World J Surg, 2014, 38(4): 947-957. DOI:10.1007/s00268-013-2365-2
[29]
Yang LY, Fang F, Ou DP, et al. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection[J]. Ann Surg, 2009, 249(1): 118-123. DOI:10.1097/SLA.0b013e3181904988
[30]
Yamashita Y, Taketomi A, Shirabe K, et al. Outcomes of hepatic resection for huge hepatocellular carcinoma (≥10 cm in diameter)[J]. J Surg Oncol, 2011, 104(3): 292-298. DOI:10.1002/jso.21931
[31]
Yin L, Li H, Li AJ, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT[J]. J Hepatol, 2014, 61(1): 82-88. DOI:10.1016/j.jhep.2014.04.005
[32]
Ho MC, Huang GT, Tsang YM, et al. Liver resection improves the survival of patients with multiple hepatocellular carcinomas[J]. Ann Surg Oncol, 2009, 16(4): 848-855. DOI:10.1245/s10434-008-0282-7
[33]
Choi SH, Choi GH, Kim SU, et al. Role of surgical resection for multiple hepatocellular carcinomas[J]. World J Gastroenterol, 2013, 19(3): 366-374. DOI:10.3748/wjg.v19.i3.366
[34]
Yang P, Wu D, Xia Y, et al. A prognostic scoring system for patients with multiple hepatocellular carcinomas treated by hepatectomy[J]. Ann Surg Oncol, 2015, 22(3): 826-833. DOI:10.1245/s10434-014-4081-z
[35]
Yau T, Tang VY, Yao TJ, et al. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma[J]. Gastroenterology, 2014, 146(7): 1691-700.e3. DOI:10.1053/j.gastro.2014.02.032
[36]
Kokudo T, Hasegawa K, Yamamoto S, et al. Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis[J]. J Hepatol, 2014, 61(3): 583-588. DOI:10.1016/j.jhep.2014.04.032
[37]
Azoulay D. Resection for hepatocellular carcinoma with hepatic vein tumour thrombus: pushing the limits beyond the guidelines frontiers[J]. J Hepatol, 2014, 61(3): 462-463. DOI:10.1016/j.jhep.2014.06.018
[38]
Inoue Y, Hasegawa K, Ishizawa T, et al. Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma?[J]. Surgery, 2009, 145(1): 9-19. DOI:10.1016/j.surg.2008.09.005
2016, Vol. 21 
